Defining the number, proportion, or lineage of distinct cell types in the developing human brain is an important goal of modern brain research. We defined single cell transcriptomic profiles for 40,000 cells at mid-gestation to identify cell types in the developing human neocortex. We define expression profiles corresponding to all known major cell types at this developmental period and identify multiple transcription factors and co-factors expressed in specific cell types, providing an unprecedented resource for understanding human neocortical development including the first single-cell characterization of human subplate neurons. We characterize major developmental trajectories during early neurogenesis, showing that cell type differentiation occurs on a continuum that involves transitions that tie cell cycle progression with early cell fate decisions. We use these data to deconvolute regulatory networks and map neuropsychiatric disease genes to specific cell types, implicating dysregulation of specific cell types, as the mechanistic underpinnings of several neurodevelopmental disorders. Together these results provide an extensive catalog of cell types in human neocortex and extend our understanding of early cortical development, human brain evolution and the cellular basis of neuropsychiatric disease.
cells to complement and extend these studies, providing a deeper picture of human cortical development.
Here we use single-cell RNA sequencing (scRNA-seq) to define cell types and compile cell type transcriptomes in the developing human neocortex. We focus on the cortical anlage at mid-gestation (gestation week (GW) 17 to 18) ( Fig. 1A) because this period contains the major germinal zones and the developing cortical laminae containing migrating and newly born neurons, and neurodevelopmental processes occurring during this epoch are implicated in neuropsychiatric disease (23, 24) . To optimize detection of distinct cell types, we separated the cortex into the germinal zones [ventricular zone (VZ) and subventricular zone (SVZ)] and developing cortex [subplate (SP) and cortical plate (CP)] prior to single-cell isolation. Using Drop-seq (5) , we obtained and compared high quality profiles for ~40,000 cells from human cortex ( Fig. 1A; fig. S1 , A and B; and tables S1 to S3), and a small subset with microfluidics approaches (Fluidigm) for technical comparisons.
We first applied standard unbiased clustering based on stochastic nearest neighbor imbedding (tSNE; see materials and methods) and spectral K-nearest neighbor graph based clustering (25) , identifying 16 transcriptionally distinct cell groups. Cell types originated from the expected anatomical source, and clustered by biological cell type rather than batch or technical artifacts ( Fig. 1, B to G and fig. S1 , C and D). We identified multiple groups of cells at different stages of neuronal differentiation and maturation, corresponding to all known major cell types at this developmental time period including: radial glia (RG), intermediate progenitors (IP), migrating, SP and CP excitatory neurons (Ex), interneurons (In), microglia (Mic), oligodendrocyte precursors (OPC), and supporting cells (endothelial cells, pericytes) ( Fig. 1, B to F; fig. S2A ; and tables S4 to S6). Clusters contained between 50 and 2,000 cells, with the smallest cluster captured, which belonged to microglia, comprised of ~50 cells, with other small clusters for oligodendrocyte precursors, endothelia, and pericytes comprised of 306, 237, 114 cells, respectively ( Fig.   1G and table S4 ). Clusters were reproducible and robust as ascertained by bootstrapping ( fig. S2B ). Ordering of cells by pseudo-time in an unbiased manner using Monocle 2, a computational method that performs lineage trajectory reconstruction based on single-cell transcriptomics data, (26, 27) confirmed the predicted developmental trajectory (Fig. 1, H and I). For example, it is possible observe the ordered transitions between different neural progenitor types and maturing glutamatergic neurons, with RG transitioning to IPs, and IPs transitioning to newborn migrating neurons ( Fig. 1I) .
Recognizing that with scRNA-seq there is an inherent practical tension between sequencing depth and the number of cells profiled, we explored the consequences of this tradeoff by performing down-sampling of sequencing depth and the number of cells analyzed to determine thresholds for cell type detection ( fig. S3 , A to D). We observed that cell type detection, especially for low abundance types appears to be more sensitive to the number of cells profiled than sequencing depth ( fig. S3 , A to D). This is also consistent with the observation that among the genes most highly expressed in a given cluster, most are specific to a cell type, and not simply highly expressed house-keeping genes ( fig. S4, A and B ). Further, while each individual cell profile is an incomplete representation of that cell type (28) , we reasoned that we could harness the power of sampling single cells at a large scale by pooling transcriptomes within cells of a given type to provide more complete cell type transcriptome representations. To evaluate the completeness of cell type signatures derived from pooling, we iteratively subsampled cells from clusters and compared the stability of gene expression signatures across iterations by ranking genes by mean expression level (figs. S4, C and D). Subsamples of 50 cells showed high stability in ranking (see materials and methods) for the top 1,000 genes, whereas 500 cells showed very high rank stability for the top 4,000 genes, allowing us to empirically assess the completeness of cell type signatures with different sample sizes (figs. S4, C and D). At a depth of 40,000 cells, we obtain stable transcriptomes representing 3,000-5,000 genes for most of the cell types present (table S5) . Comparison of these data with a lower throughput, higher sequencing depth method (Fluidigm C1, (19) , fig. S5 ), revealed that although Fluidigm C1 detected a greater number of genes on average from individual cells, the ability to leverage an order of magnitude more cells with Drop-seq provided more stable mRNA transcript profiles for a given cell type ( fig. S5 , A to C). We provide these cell type specific expression profiles with annotated gene expression ranking confidence measures for each cell type (table S5) .
To further evaluate the quality of scRNA-seq transcriptomic catalogs, we compared scRNA-seq datasets produced from different technologies and laboratories to bulk RNAseq expression profiles from human fetal cortex (29) . We reasoned that pooling scRNAseq expression profiles from many cells from a tissue would reveal the magnitude to which single cell protein-coding transcriptomes approximate bulk tissue expression profiles.
Consistently, gene expression profiles generated using different scRNA-seq methodologies strongly correlated with bulk RNA-seq gene expression profiles (Spearman 0.69-0.83) ( fig. S6, A and B ). However, we did observe a group of approximately 400 protein coding genes that were consistently under-represented in single-cell datasets across the methods and laboratories compared to bulk tissue RNA-seq (fig. S6, C and D).
These genes encoded cell adhesion molecules, were significantly longer, brain enriched, and involved in neuronal development ( fig. S6 , E to H). The differences between scRNAseq methods and bulk tissue RNA-seq may be due to mapping differences between poly-A primed scRNA-seq datasets and rRNA depleted full length mRNA bulk tissue RNA-seq, or dissociation procedures common to all scRNA-seq methods. However, comparison of expression of canonical cell type marker genes showed similar expression levels compared to bulk tissue RNA-seq ( fig. S6I ). This indicates that despite small biases in gene detection shared across scRNA-seq methods, the relative frequencies of major cell types were not over-or under-represented in the Drop-seq dataset. In conjunction with the high correlation with bulk tissue RNA-seq this demonstrates the reproducibility and robustness of the scRNA-seq dataset (fig. S6, A and I).
Having ascertained the quality and robustness of the cell clusters and associated gene expression profiles, we reasoned that we could gain insight into cell type specific regulatory programs by comparing transcription factor expression across cell types.
Indeed, we find previously characterized transcription factors and co-factors enriched in their corresponding cell types ( Figs. 1F and 2A) . In addition, we find several transcription factors and co-factors (ZFHX4, CARHSP1, ST18, and CSRP2) that have not been associated with specific neocortical cell types ( Fig. 2A) . These transcription factors also displayed laminae-specific expression in a bulk tissue laser captured micro-dissected (LCM) expression dataset (30) , and temporal trajectories similar to canonical cell type markers (Fig. 2, A To validate predictions for these putative novel cell type markers, we performed RNA FISH, which confirmed laminae-specific expression of each of the transcription factors and co-factors tested: ZFHX4 and CARHSP1 in RG, ST18 in the SP, and CSRP2 in excitatory neurons (Fig. 2, C and D) . Of particular interest was ZFHX4, which has been previously associated with 8q21.11 microdeletion, a syndrome characterized by intellectual disability, hypotonia, decreased balance, sensorineural hearing loss, and unusual behavior (33) .
Our data localizes ZFHX4 specifically to RG in the developing human neocortex for the first time, implicating specific dysregulation of RG as the mechanism underlying 8q21.11 microdeletion syndrome.
A first step in understanding the regulatory mechanisms active in the human neocortex is assigning the activity of regulatory elements to specific cell types. To deconvolute the cell type specificity of regulatory elements in human fetal cortex we leveraged a recently generated map of regulatory elements active in developing fetal cortex and their putative target genes (29) . Using this map, we identify promoters and enhancers regulating the expression of genes enriched in each of the cell clusters defined in this study (see with previous observations (37% based on immunostaining) (34) . Remarkably, we also observed that many of the cycling progenitors individually expressed markers of several distinct major cell types, including RGs, IPs, and neurons ( Fig. 3 , A to C). Doublets were an insufficient explanation for the co-expression of distinct cell type makers for multiple reasons, including that the number of cells expressing multiple major cell type markers is twice the empirically assessed doublet rate (table S2 and fig. S1B-also see materials and methods) and the highly non-random distribution of the cell types expressing markers of two cell types ( Fig. 3C) .
Therefore, as an alternative explanation, we hypothesized that we were identifying an intermediate or transition state: mitotically active cells in the early stages of neurogenesis, i.e. RG producing IP, RG producing neurons, and IP producing neurons. Consistent with this hypothesis, mixed marker cells progressing through different stages of the cell cycle consistently displayed transcriptomes comprised of multiple major cell types ( Fig. 3D and fig. S11, A and B). By S-phase, RG+IP+ and IP+Neuron+ cells more closely resembled their presumed endpoint cell type, IP and neuron, respectively ( Fig. 3D and fig S11B) . The transcriptomic signature of RG+Neuron+ S-phase and G2/M phase cells was closer to RG, potentially reflecting the greater dissimilarity between RG and neurons ( Fig. 3D and fig. S11, A and B). In addition, the mixed marker cells share a high percentage of the end point cell type signature, but the magnitude of expression of the cell type relevant signature genes is smaller than in cells in the fully differentiated cell clusters ( Fig. 3E and fig. S11, C to F). Mixed marker cells not in S, G2, or M phase may represent cells starting to cycle and differentiate, consistent with findings in mice that some radial glial precursors also express neuronal marker genes of both deep and superficial layers, representing transcriptionally primed cells (35) . Alternatively, these mixed marker cells may be newborn cells that still retain some transcripts of the mother cell type, as has been previously suggested in mice (18, 35) .
To independently validate the existence of cells in these transition states, we performed RNA FISH, observing S-phase neural progenitors in the VZ expressing both PAX6 and STMN2, indicating an induction of a neuronal program in a single cell before its neurogenic division ( Fig. 3F) . Quantification of 872 cells across the germinative layers indicated that 6.1% (VZ), 5.8% (iSVZ) and 8.2% (oSVZ) of these cells co-express markers of RG and neurons, confirming our scRNA-seq data (see materials and methods). Given that mixed marker cells are indicative of a single cell transition state during early neurogenesis, we were able to quantify the relative proportions of progenitors undergoing distinct differentiation divisions ( Fig. 3G) , finding that RG produce roughly equal numbers of RG, IP, and neurons, but that IP produce approximately two times as many neuronal progeny as IP progeny. Taken together, these results indicate that during early neurogenesis: 1)
Cell fate decisions occur prior to S-phase; 2) Differentiating "parent" cells not only express the few key transcription factors that drive cell fates, but express broad, mixed cell type transcriptomes; 3) Neural cell-type differentiation occurs on a continuum and involves transcriptomic transitions tied to cell cycle progression ( Fig. 3H ). An early cell fate decision point tied to cell cycle is consistent with previous work indicating cell fate decisions in neurogenesis are made in G1 (36, 37) . However, previous models of asymmetric neurogenic divisions suggest that only a few key transcription factors of the "daughter" lineage are expressed in the asymmetrically dividing cell, whereas we observe early induction of more extensive cell type transcriptional programs (36, 37) . Cells are producing transcriptomes representing two cell types from a single nucleus, prior to cytokinesis, demonstrating the usefulness of single-cell transcriptomics for furthering our understanding the transcriptional dynamics involved in early neural development (38, 39) .
We next reasoned that we could begin to leverage these single cell data to uncover some of the cellular and molecular mechanisms driving human cortical evolution by determining whether specific cell types were enriched with genes showing human-specific expression trajectories (hSET) in bulk tissue (40) (see materials and methods). We observed the strongest enrichment of hSET genes in outer radial glia (oRG) and callosal neurons, an upper layer excitatory subtype ( fig. S12A ). This is notable, since both of these cell types represent core processes involved in both neocortical expansion (16) Using a similar logic, we reasoned that we could use this deep molecular atlas of developing human brain cell types to identify the developmental stages and cell types where mutations causing high risk for neuropsychiatric disease act, so as to provide a reference for understanding disease mechanisms and circuits. We first examined enrichment of high confidence autism spectrum disorder (ASD) risk genes, defined by harboring high risk likely protein-disrupting mutations (44) ( Fig. 4A and fig. S13 ). The majority of ASD-risk genes were expressed in developing glutamatergic neurons, both deep and upper layer (Fig. 4A) , consistent with previous studies (45, 46) . However, at the individual gene level, there is substantial variability, and several genes are expressed in inhibitory neurons as well as excitatory neurons or progenitors ( Fig. 4A and fig. S13 ). For example, MYT1L and AKAP9 display pan neuronal expression, whereas GRIN2B is glutamatergic subtype specific, and ILF2 is expressed in cycling progenitors ( Fig. 4A and   fig. S13 ). In adult, expression again concentrated in glutamatergic neurons, with some genes exhibiting more pan-neuronal expression patterns.
In addition, our expanded atlas of cell types identified several genes that showed remarkably distinct patterns of extra-neuronal expression, including SLC6A1, which was enriched in pericytes, and TRIO, SETD5, TCF7L2, and KAT2B, which were enriched in oligodendrocyte precursors ( Fig. 4A and fig. S13 ). These data implicate these cell types involved in maintenance of the blood brain barrier and the peri-neural environment for the first time in ASD risk. We then expanded this analysis to high confidence intellectual disability (ID) and epilepsy risk genes, (Fig. 4, B and C, and figs. S14 to S16). The majority of epilepsy-risk genes are also expressed in glutamatergic neurons in fetal and adult cortex ( Fig. 4C and figs . S14 and S15). ID risk genes were also enriched in glutamatergic neurons, but interestingly also showed enrichment in RG, which was not observed with ASD or epilepsy. The impact on early progenitor types in ID relative to ASD and epilepsy is consistent with the more severe disease phenotype in ID ( Fig. 4B and fig.   S16 ). Taken together, these results demonstrate cell type specific expression of ASD, epilepsy, and ID risk genes by mid fetal development and provide a framework for the cellular and developmental context in which individual ASD, epilepsy, and ID genes should optimally be studied.
The majority of neuropsychiatric disease risk loci are found in the non-coding genome, where functional interpretation is hampered by limited knowledge of the genomic location and spatiotemporal activity of regulatory elements. Leveraging our cell type specific map of regulatory elements active in the human neocortex ( Fig. 4D and table S7 , see materials and methods), (29) we used a partitioned heritability approach based on LD score regression (47) to identify cell types enriched for variants influencing brain volume, cognition, or causing risk for neuropsychiatric disease (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) . We found that variants influencing adult intracranial volume were specifically enriched in the regulatory elements of cycling progenitors (PgS, PgG2M), pinpointing a specific cell type and state likely associated with neural progenitor expansion ( Fig. 4E and fig. S17 ). Importantly, by connecting causal genetic drivers to specific genes within a specific cell type, this not only identifies putative cell-type specific mechanisms involved in cortical expansion, but provides further support for the radial unit hypothesis of cortical expansion on the human lineage (16, 64) .
In contrast, common genetic variants influencing general cognition (IQ) were enriched in cycling neural progenitors, cortical plate glutamatergic neurons, SST inhibitory neurons, and intriguingly in pericytes ( Fig. 4E and fig. S17 ). A less powered IQ genome-wide association study (GWAS) also found enrichment in maturing cortical plate glutamatergic neurons, but not in other cell types ( Fig. 4E and fig. S17 ). Variants causing risk for schizophrenia were enriched in multiple cell types, including neural progenitors, glutamatergic neurons, interneurons, oligodendrocyte precursors and microglia (Fig. 4E   and fig. S17 ). A recent study, using a partitioned heritability approach, found enrichment for schizophrenia variants in adult cortical glutamatergic neurons and cortical interneurons, consistent with bulk tissue analysis (65), but was unable to assess enrichment in human fetal cortical cell types given a lack of available data (66). Thus, our results now also implicate neural progenitors, oligodendrocyte precursors and fetal microglia in schizophrenia, highlighting the importance of generating single-cell resources from multiple time periods and brain regions. We did not observe enrichment of IBD or finger whorl variants ( Fig. 4E and fig. S17 ) in the regulatory elements of any of the cortical derived cell types, supporting the cell type specificity of gene regulation. These results highlight how combining DNA accessibility profiling and single-cell sequencing can facilitate interpretation of the function of variants influencing brain structure and function.
This resource of transcriptomic profiles of 40,000 single cells in human fetal cortex demonstrates the utility of single-cell analysis for characterizing human neurogenesis, identifying novel cell type regulatory mechanisms, and for understanding the cellular basis of brain phenotypes with neurodevelopmental origins. By expanding the publicly available number of human fetal brain single-cell transcriptomes by an order of magnitude, these data provide more complete cell type mRNA transcript profiles, and permit discovery and characterization of rare cell types and states (18) (19) (20) (21) (22) . These data implicate early decision points in cell fate trajectories that are pre S-phase, leading to transcriptomically mixed cell states, and highlighting the importance of sampling single cells at a massive scale to capture rare types and states. The transition state dynamics during early neurogenesis show that cell type differentiation is on a gradual continuum and involves transcriptomic transitions tied to cell cycle progression.
We also identify novel cell type enrichment of regulatory genes and elements and highlight how this can be used to identify critical cell types in monogenic disorders (e.g. ZFHX4 and 8q21.11 deletion), as well as in ASD, expanding the implicated cell landscape in this disorder to include inhibitory neurons and non-neural cells in addition to glutamatergic neurons. The importance of cell type specific gene regulation underscores the importance of expanding single-cell taxonomies in the future to include single-cell epigenetic analysis to supplement the rich information contained in scRNA-seq catalogs as recently demonstrated (67) . Lastly, we show that genes with human specific expression patterns act preferentially in oRG and upper cortical layer neurons, which is consistent with the expansion of these zones during brain evolution. These data provide a molecular context for cortical expansion and increased cortical-cortical connectivity in humans, and extend our understanding of developmental dynamics and the origin of neuropsychiatric disease risk in human neocortex.
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